GEVA

Synageva BioPharma Corp. Stock Report

$42.28
*  
1.31
  negative  
3.2%
Get GEVA Alerts
*Delayed - data as of Jun. 17, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
NASDAQ-GS
Online Stock Report   |  Print Friendly Version   |   Free Annual Report

Stock Report Details

Issue Type Common Stock Exchange NASDAQ-GS
52 Weeks High 58 52 Weeks Low 35.69
Dividend Yield 0 % Annual Dividend N/A
P/E Ratio NE Shares Outstanding 26,617,000

12 Month stock report for GEVA